VIEWPOINTS


Viewpoints are a collection of news and opinion articles that capture key research developments and important issues in the field of oncology.


Statin Therapy May Help Delay Prostate Cancer Progression in Men Receiving ADT

Statin Therapy May Help Delay Prostate Cancer Progression in Men Receiving ADT

Researchers indicate a link between statin use and delay in prostate cancer progression.

Functional Adaptive Hyperfiltration May Affect Renal Function after Radical Nephrectomy

Functional Adaptive Hyperfiltration May Affect Renal Function after Radical Nephrectomy

Adaptive hyperfiltration may be more important than structural adaptive hypertrophy for the recovery of renal function following radical nephrectomy.

Older Adults with Head and Neck Cancers May Need More Cautious Treatment Strategies

Older Adults with Head and Neck Cancers May Need More Cautious Treatment Strategies

Research from ASCO indicates treatment of locally advanced head and neck cancer should be carefully considered in patients older than 70.

ASPEN Compares Sunitinib, Everolimus in Metastatic Non-Clear Cell Renal Cell Carcinoma

ASPEN Compares Sunitinib, Everolimus in Metastatic Non-Clear Cell Renal Cell Carcinoma

Randomized trial identifies potential first-line therapy for patients with non-clear cell renal cell carcinoma.

Organoid Biobanks in Colon Cancer Show Promise in Personalized Treatment Options

Organoid Biobanks in Colon Cancer Show Promise in Personalized Treatment Options

Combining a previously established culture medium, researchers were able to create a colon tissue organoid, which could have implications for personalized treatment.

Nivolumab Shows Promising Efficacy, Safety in Advanced Hepatocellular Carcinoma

Nivolumab Shows Promising Efficacy, Safety in Advanced Hepatocellular Carcinoma

Patients with hepatocellular carcinoma (HCC) who have advanced on sorafenib have poor prognosis and few additional treatment options.

Results of Nivolumab CheckMate 057 Study May Change Treatment of Lung Cancer

Results of Nivolumab CheckMate 057 Study May Change Treatment of Lung Cancer

Options for treatment of patients with non-squamous non-small cell lung cancer (NSCLC) who progress after initial therapy are limited.

Identifying Genetic Variations Associated with Risk of Prostate Cancer

Identifying Genetic Variations Associated with Risk of Prostate Cancer

While data confirmation is needed, recent findings may prove beneficial in identifying patients at a high risk of developing prostate cancer.

Study Suggests Renal Cell Carcinoma Reprograms its Metabolism to Evade Immune System

Study Suggests Renal Cell Carcinoma Reprograms its Metabolism to Evade Immune System

Researchers used a sophisticated combination of proteomics and metabolomics to show how RCC reprograms its metabolism and evades the immune system.

Do Patients with Locally Advanced Rectal Cancer Benefit from Adjuvant Chemotherapy?

Do Patients with Locally Advanced Rectal Cancer Benefit from Adjuvant Chemotherapy?

A recent letter in JCO discusses whether patients with locally advanced rectal cancer need adjuvant chemotherapy.

Next-Generation Sequencing Panels Cost-Effective for Diagnosis of Hereditary Colorectal Cancer

Next-Generation Sequencing Panels Cost-Effective for Diagnosis of Hereditary Colorectal Cancer

A decision model finds that the higher cost of new sequencing methods is justified by their clinical benefits.

Vitamin D Levels and Risk for Pancreatic Cancer

Vitamin D Levels and Risk for Pancreatic Cancer

Recent reports indicate a potential association between sunlight exposure and risk of pancreatic cancer.

New Genetic Sequencing May Lead to Urine Test for Bladder Cancer

New Genetic Sequencing May Lead to Urine Test for Bladder Cancer

Early research indicates the possibility for a urine test for bladder cancer.

Will Patient-Reported Outcomes Be Included in Oncology Product Labeling?

Will Patient-Reported Outcomes Be Included in Oncology Product Labeling?

FDA, industry, and patients are talking, but agreement on how to include patient experiences in oncology product prescribing information remains elusive.

Bipolar Androgen Therapy Showing Promise for Castration Resistant Prostate Cancer

Bipolar Androgen Therapy Showing Promise for Castration Resistant Prostate Cancer

Bipolar androgen therapy (BAT) may benefit some men with asymptomatic CRPC who have a low to moderate metastatic burden.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs